Results from a phase 1 trial have supported further clinical evaluation with a dose-dependent WL up to 14.5% with AMG133 compared to 1.5% with placebo by day 85 [59]
Technical/Research Applications BPC 157 may be applied as a laboratory comparison article for peptide identity mapping, receptor-binding assay controls, LC-MS sequence confirmation, lyophilized-material comparability, and biochemical pathway calibration
Available: J Altern Complement Med, Intravenous Micronutrient Therapy (Myers Cocktail) for Fibromyalgia: A Placebo-Controlled Pilot Study, March 2009
Keep refrigerated Do not cook or heat product Keep out of reach of children Do not use in conjunction with other medications without consulting your veterinarian
L.NorhaizanM
Epithalon, upon delivery, appeared to inhibit the process of metastasis in the mice, preventing tumor cell cycle and growth